Author

Mark S. Carey

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Low-grade serous ovarian cancer: 2026 expert consensus report.

Low-grade serous ovarian carcinoma (LGSOC) is a rare epithelial malignancy characterized by frequent mitogen-activated protein kinase (MAPK) pathway alterations, hormone receptor expression, relative resistance to cytotoxic chemotherapy, and a prolonged, relapsing clinical course. Since publication of the 2023 internat...

R. Grisham, B. Slomovitz, V. Podder et al. · Gynecologic Oncology · 0 citations

Review Open access Oct 2026

Exploring patient and clinician perspectives for homologous recombination deficient (HRD) biomarker testing to guide precision medicine for advanced ovarian cancer treatment: A qualitative study.

OBJECTIVE To explore the knowledge, attitudes, and experiences of advanced ovarian cancer patients and clinicians regarding homologous recombination deficiency (HRD) testing in Canada to offer a more comprehensive understanding of the real-world implications of HRD testing, and help improve patient-informed decision-ma...

Julia McKenna, Rachelle Payandeh, Yelena Aizenberg et al. · Patient Education and Counse... · 0 citations